State III squamous cell carcinoma of the vulva. Results of a Swedish study

One hundred fifty-three cases of stage III vulvar squamous cell carcinoma were studied. The survival rate was significantly higher in the 99 patients given standard treatment than in the 54 given other treatments. The principal prognostic factor was the presence of groin metastases. In cases without...

Full description

Saved in:
Bibliographic Details
Published inJournal of reproductive medicine Vol. 36; no. 2; p. 108
Main Author Frankman, O
Format Journal Article
LanguageEnglish
Published United States 01.02.1991
Subjects
Adult
Aged
Aged, 80 and over
Carcinoma, Squamous Cell - mortality
Carcinoma, Squamous Cell - pathology
Carcinoma, Squamous Cell - therapy
Combined Modality Therapy
Evaluation Studies as Topic
Female
Humans
Lymphatic Metastasis
Middle Aged
Neoplasm Staging
Prognosis
Retrospective Studies
Sweden
Vulvar Neoplasms - mortality
Vulvar Neoplasms - pathology
Vulvar Neoplasms - therapy
Sweden
Online AccessGet more information

Cover

More Information
Summary:One hundred fifty-three cases of stage III vulvar squamous cell carcinoma were studied. The survival rate was significantly higher in the 99 patients given standard treatment than in the 54 given other treatments. The principal prognostic factor was the presence of groin metastases. In cases without metastases at the time of primary treatment, the five-year survival rate was 89%; in cases with metastases it was 36% When nodal metastases were not suspected (International Federation of Obstetricians and Gynecologists stage N0N1), the survival rate was also higher than when nodal involvement was suspected (N2). Stage III should be subdivided according to either postoperative stages or new clinical stages by separating N0N1 cases from N2 cases.
ISSN:0024-7758